Skip to main content

Sympathetic Innervation and Blood Flow in the Diabetec Heart

  • Chapter
Book cover Catecholamine Research

Part of the book series: Advances in Behavioral Biology ((ABBI,volume 53))

Abstract

The balance of the activity of the cardiac sympathetic and parasympathetic nervous system plays a key role for the functional and structural performance of the diabetic heart.1 Metabolic, vascular/hemorrheological and, in type 1 diabetes mellitus, immunological factors are currently hypothezised to contribute to the pathogenesis, which, however, has not been fully elucidated.1 The heterogeneous pattern and the high extent of dysfunction of the cardiac sympathetic nervous system in diabetes mellitus had remained largely unknown until advanced scintigraphic techniques for direct characterization of dysfunction of sympathetic neurons in the living heart emerged in the 1990’s. Previously, diagnosis of cardiac sympathetic abnormalities had been mainly based on conventional non-invasive cardiac reflex tests, including measurements of heart rate variation and blood pressure changes to standing. These tests, however, only indirectly assess diabetic cardiac autonomic dysfunction, they do not differentiate absolutely between sympathetic and parasympathetic function and they do not assess the heart regionally. Imbalance of the activity of the cardiac sympathetic nervous system is suggested to lead to multiple functional disturbances and to increase the risk for arrythmogenicity of the diabetic heart.2

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. E. Standi, O. Schnell. A new look upon the heart in diabetes mellitus: from ailing to failing. Diabetologia 43: 1455–1469 (2000)

    Article  Google Scholar 

  2. O. Schnell, C.-M. Kirsch, J. Stemplinger, M. Haslbeck, E. Standi. Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term Type 1 diabetic patients with and without ECG-based autonomic neuropathy. Diabetologia 38:1345–1352 (1995)

    Article  PubMed  CAS  Google Scholar 

  3. M. Mäntysaari, J. Kuikka, J. Mustonen, K. Tahvanainen, E. Vanninen, E. Länsimies, M. Uusitupa: Noninvasive detection of cardiac sympathetic nervous dysfunction in diabetic patients using (123I) metaiodobenzylguanidine. Diabetes 41: 1069–1075 (1992)

    Article  PubMed  Google Scholar 

  4. A. Langer, M.R. Freeman, R.G. Josse, P.W. Armstrong: Metaiodobenzylguanidine imaging in diabetes mellitus: Assessment of cardiac sympathetic dysinnervation and its relation to autonomic dysfunction and silent myocardial ischemia. J Am Coll Cardiol 25: 610–618 (1995)

    Article  PubMed  CAS  Google Scholar 

  5. O. Schnell, D. Muhr, M. Weiss, S. Dresel, M. Haslbeck, E. Standi. Reduced myocardial 123I-metaiodobenzylguanidine uptake in newly diagnosed IDDM patients. Diabetes 45:801–805 (1996)

    Article  PubMed  CAS  Google Scholar 

  6. M.A. Pfeifer, M.P. Schumer: Perspectives in Diabetes: Clinical trials of diabetic neuropathy: past, present, and future: Diabetes 44: 1355–1361 (1995)

    Article  PubMed  CAS  Google Scholar 

  7. O. Schnell, D. Muhr, S. Dresel, M. Weiss, M. Haslbeck, E. Standi. Partial restoration of scintigraphically assessed cardiac sympathetic denervation in newly diagnosed patients with insulin dependent (Type 1) diabetes mellitus at one-year follow-up. Diabetic Medicine 14:57–62 (1997)

    Article  PubMed  CAS  Google Scholar 

  8. D. Muhr-Becker, M. Weiss, K. Tatsch, G. Wolfram, E. Standi, O. Schnell. Scintigraphically assessed cardiac sympathetic dysinnervation in poorly controlled type 1 diabetes mellitus: One-year follow-up with improved metabolic control. Exp Clin Endocrinol Diabetes 107:306–312 (1999)

    Article  PubMed  CAS  Google Scholar 

  9. O. Schnell, D. Muhr, M. Weiss, C.M. Kirsch, M. Haslbeck, E. Standi. Three-year follow-up on scintigraphically assessed cardiac sympathetic denervation in patients with long-term Insulin Dependent (Type 1) Diabetes mellitus. J Diab Compl, 11:307–313 (1997)

    Article  CAS  Google Scholar 

  10. K.C. Allman, M.J. Stevens, D.M. Wieland, G.D. Hutchins, E.R. Wolfe, D.A. Greene, M. Schwaiger. Noninvasive assessment of cardiac diabetic neuropathy by C11 hydroxyephedrine and positron emission tomography. J Am Coll Cardiol 22: 1425–1432 (1993)

    Article  PubMed  CAS  Google Scholar 

  11. M.J. Stevens, D.M. Raffel, K.C. Allman, F. Dayanikli, E. Ficaro, T. Sandford, D.M. Wieland, M.A. Pfeifer, M. Schwaiger et al. Cardiac sympathetic dysinnervation in diabetes. Circulation 98: 961–968 (1998)

    Article  PubMed  CAS  Google Scholar 

  12. O. Schnell, D. Muhr, S. Dresel, K. Tatsch, A.G. Ziegler, M. Haslbeck, E Standi. Autoantibodies against sympathetic ganglia and evidence of cardiac sympathetic dysinnervation in newly diagnosed and long- term IDDM patients. Diabetologia 39:970–975 (1996)

    Article  CAS  Google Scholar 

  13. D. Muhr, U. Mollenhauer, A. Ziegler, M. Haslbeck, E. Standi, O. Schnell. Autoantibodies to sympathetic ganglia, GAD, or tyrosine phosphatase in long-term IDDM with and without ECG-based cardiac autonomic neuropathy. Diabetes Care 20:1009–1012 (1997)

    Article  PubMed  CAS  Google Scholar 

  14. O. Schnell, A. Schwarz, D. Muhr-Becker, E. Standi: Cardiac autonomic dysfunction in Type 2 Diabetes mellitus: No association with autoantibodies against autonomic nervous tissues. Exp Clin Endocrinol Diabetes 108: 181–186 (2000)

    Article  PubMed  CAS  Google Scholar 

  15. M. Schwaiger, J. Melin. Cardiological applications of nuclear medicine. Lancet 354: 661–666 (1999)

    Article  PubMed  CAS  Google Scholar 

  16. M.F. Di Carli, D. Bianco-Batlles, M.E. Landa, A. Kazmers, H. Groehn, O. Muzik, G. Grunberger. Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus. Circulation 100: 813–819 (1999)

    Article  PubMed  Google Scholar 

  17. A.M. Zeiher, H. Drexler, H. Wollschlager, B. Saurbier, H Just. Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium. J Am Coll Cardiol 14: 1181–1190(1989)

    Article  PubMed  CAS  Google Scholar 

  18. M.R. Kichuk, N. Seyedi, X Zhang et al. Regulation of nitric oxide production in human coronary microvessels and the contribution of local kinin formation. Circulation 94:44–51 (1996)

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

Schnell, O. (2002). Sympathetic Innervation and Blood Flow in the Diabetec Heart. In: Nagatsu, T., Nabeshima, T., McCarty, R., Goldstein, D.S. (eds) Catecholamine Research. Advances in Behavioral Biology, vol 53. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-3538-3_120

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-3538-3_120

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4419-3388-1

  • Online ISBN: 978-1-4757-3538-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics